Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

School-based surveillance for influenza vaccine effectiveness during 2014-2015 seasons in Hong Kong.

Leung TF, Chan RWY, Kwok A, Ho WCS, Tao MKP, Hon KL, Cheng FWT, Li AM, Chan PKS.

Influenza Other Respir Viruses. 2017 Jul;11(4):319-327. doi: 10.1111/irv.12455. Epub 2017 May 25.

2.

Cost-effectiveness of quadrivalent influenza vaccine in Hong Kong - A decision analysis.

You JH, Ming WK, Chan PK.

Hum Vaccin Immunother. 2015;11(3):564-71. doi: 10.1080/21645515.2015.1011016.

3.

Validation of Health Event Capture in the Marshfield Epidemiologic Study Area.

Kieke AL, Kieke BA Jr, Kopitzke SL, McClure DL, Belongia EA, VanWormer JJ, Greenlee RT.

Clin Med Res. 2015 Dec;13(3-4):103-11. doi: 10.3121/cmr.2014.1246. Epub 2014 Dec 8.

4.

Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong.

You JH, Ming WK, Chan PK.

BMC Infect Dis. 2014 Nov 25;14:618. doi: 10.1186/s12879-014-0618-9.

5.

Suppression of influenza A virus replication in human lung epithelial cells by noncytotoxic concentrations bafilomycin A1.

Yeganeh B, Ghavami S, Kroeker AL, Mahood TH, Stelmack GL, Klonisch T, Coombs KM, Halayko AJ.

Am J Physiol Lung Cell Mol Physiol. 2015 Feb 1;308(3):L270-86. doi: 10.1152/ajplung.00011.2014. Epub 2014 Oct 31.

6.

Intranasal delivery of influenza rNP adjuvanted with c-di-AMP induces strong humoral and cellular immune responses and provides protection against virus challenge.

Sanchez MV, Ebensen T, Schulze K, Cargnelutti D, Blazejewska P, Scodeller EA, Guzmán CA.

PLoS One. 2014 Aug 20;9(8):e104824. doi: 10.1371/journal.pone.0104824. eCollection 2014.

7.

Genetic and antigenic typing of seasonal influenza virus breakthrough cases from a 2008-2009 vaccine efficacy trial.

Durviaux S, Treanor J, Beran J, Duval X, Esen M, Feldman G, Frey SE, Launay O, Leroux-Roels G, McElhaney JE, Nowakowski A, Ruiz-Palacios GM, van Essen GA, Oostvogels L, Devaster JM, Walravens K.

Clin Vaccine Immunol. 2014 Mar;21(3):271-9. doi: 10.1128/CVI.00544-13. Epub 2013 Dec 26.

8.

Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination.

Jiménez-Jorge S, de Mateo S, Delgado-Sanz C, Pozo F, Casas I, Garcia-Cenoz M, Castilla J, Pérez E, Gallardo V, Rodriguez C, Vega T, Quiñones C, Martínez E, Vanrell JM, Giménez J, Castrillejo D, Serrano Mdel C, Ramos JM, Larrauri A; Spanish Influenza Sentinel Surveillance System.

BMC Infect Dis. 2013 Sep 22;13:441. doi: 10.1186/1471-2334-13-441.

9.

Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA.

Julien JP, Lee PS, Wilson IA.

Immunol Rev. 2012 Nov;250(1):180-98. doi: 10.1111/imr.12005. Review.

10.

Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains.

Treanor JJ, Talbot HK, Ohmit SE, Coleman LA, Thompson MG, Cheng PY, Petrie JG, Lofthus G, Meece JK, Williams JV, Berman L, Breese Hall C, Monto AS, Griffin MR, Belongia E, Shay DK; US Flu-VE Network.

Clin Infect Dis. 2012 Oct;55(7):951-9. Epub 2012 Jul 25.

11.

Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans.

Lillie PJ, Berthoud TK, Powell TJ, Lambe T, Mullarkey C, Spencer AJ, Hamill M, Peng Y, Blais ME, Duncan CJ, Sheehy SH, Havelock T, Faust SN, Williams RL, Gilbert A, Oxford J, Dong T, Hill AV, Gilbert SC.

Clin Infect Dis. 2012 Jul;55(1):19-25. doi: 10.1093/cid/cis327. Epub 2012 Mar 22.

12.

Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010.

Fielding JE, Grant KA, Garcia K, Kelly HA.

Emerg Infect Dis. 2011 Jul;17(7):1181-7. doi: 10.3201/eid1707.101959.

13.

A highly conserved neutralizing epitope on group 2 influenza A viruses.

Ekiert DC, Friesen RH, Bhabha G, Kwaks T, Jongeneelen M, Yu W, Ophorst C, Cox F, Korse HJ, Brandenburg B, Vogels R, Brakenhoff JP, Kompier R, Koldijk MH, Cornelissen LA, Poon LL, Peiris M, Koudstaal W, Wilson IA, Goudsmit J.

Science. 2011 Aug 12;333(6044):843-50. doi: 10.1126/science.1204839. Epub 2011 Jul 7.

14.

Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008.

Fielding JE, Grant KA, Papadakis G, Kelly HA.

BMC Infect Dis. 2011 Jun 14;11:170. doi: 10.1186/1471-2334-11-170.

15.

Comparison of clinical features and outcomes of medically attended influenza A and influenza B in a defined population over four seasons: 2004-2005 through 2007-2008.

Irving SA, Patel DC, Kieke BA, Donahue JG, Vandermause MF, Shay DK, Belongia EA.

Influenza Other Respir Viruses. 2012 Jan;6(1):37-43. doi: 10.1111/j.1750-2659.2011.00263.x. Epub 2011 May 25.

16.

Immunologic non-inferiority of a newly licensed inactivated trivalent influenza vaccine versus an established vaccine: a randomized study in US adults.

Campbell JD, Chambers CV, Brady RC, Caldwell MC, Bennett NL, Fourneau MA, Jain VK, Innis BL.

Hum Vaccin. 2011 Jan 1;7(1):81-8. Epub 2011 Jan 1.

17.

Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1.

Berthoud TK, Hamill M, Lillie PJ, Hwenda L, Collins KA, Ewer KJ, Milicic A, Poyntz HC, Lambe T, Fletcher HA, Hill AV, Gilbert SC.

Clin Infect Dis. 2011 Jan 1;52(1):1-7. doi: 10.1093/cid/ciq015.

18.

Evaluation of targeted influenza vaccination strategies via population modeling.

Glasser J, Taneri D, Feng Z, Chuang JH, Tüll P, Thompson W, Mason McCauley M, Alexander J.

PLoS One. 2010 Sep 17;5(9). pii: e12777. doi: 10.1371/journal.pone.0012777.

19.

All-cause mortality during first wave of pandemic (H1N1) 2009, New South Wales, Australia, 2009.

Muscatello DJ, Cretikos MA, Macintyre CR.

Emerg Infect Dis. 2010 Sep;16(9):1396-402. doi: 10.3201/eid1609.091723.

20.

Establishment and characterization of a Madin-Darby canine kidney reporter cell line for influenza A virus assays.

Hossain MJ, Perez S, Guo Z, Chen LM, Donis RO.

J Clin Microbiol. 2010 Jul;48(7):2515-23. doi: 10.1128/JCM.02286-09. Epub 2010 May 26.

Supplemental Content

Support Center